Lv11
100 积分 2024-12-06 加入
Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis
3小时前
待确认
Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
22天前
已完结
Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study
22天前
已完结
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trial
22天前
已完结
Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-blind, placebo-controlled study through week 12
22天前
已关闭
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
2个月前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
2个月前
已完结
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
3个月前
已完结
Ixekizumab or secukinumab in psoriasis: what difference does it make?
4个月前
已完结
Vunakizumab: First Approval
4个月前
已完结
皖公网安备34019202002308
